Mr Imaging: Clinical Trials

645 trials of Mr Imaging, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

269 recruiting, 202 active not recruiting, 47 completed, 40 not yet recruiting. 340 Phase 2, 174 Phase 1, 101 Phase 3, 50 Not applicable, 17 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 2340Recruiting 138, Active not recruiting 124, Not yet recruiting 23, Withdrawn 19, Completed 13, Suspended 11, Terminated 11, Enrolling by invitation 1
Phase 1174Recruiting 76, Active not recruiting 50, Suspended 12, Not yet recruiting 11, Withdrawn 11, Terminated 9, Completed 4, Unknown 1
Phase 3101Recruiting 43, Active not recruiting 39, Not yet recruiting 7, Completed 5, Suspended 4, Terminated 3
Not applicable50Recruiting 18, Completed 15, Active not recruiting 6, Not yet recruiting 4, Withdrawn 4, Terminated 3
Early Phase 117Recruiting 9, Active not recruiting 4, Completed 3, Terminated 1
Phase 45Recruiting 4, Completed 1

Follow Mr Imaging: new trials by email Literature Review of Mr Imaging trials Research Report on Mr Imaging

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Preoperative Durvalumab, Cisplatin, Gemcitabine With or Without Futibatinib Targeted Therapy for the Treatment of Resectable Intrahepatic Cholangiocarcinoma, OPTIC Trial
Biospecimen Collection, Cisplatin, Computed Tomography - Resectable Intrahepatic Cholangiocarcinoma
Phase 2Not yet recruitingNorthwestern University442027-12-102026-06-10
Futibatinib With Paclitaxel and Ramucirumab for the Treatment of Locally Advanced or Unresectable Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
Biospecimen Collection, Computed Tomography, Futibatinib - Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Esophageal Adenocarcinoma AJCC v8
Phase 1Not yet recruitingNorthwestern University182027-09-092026-10-20
Zanubrutinib and Sonrotoclax for the Treatment of Relapsed Chronic Lymphocytic Leukemia /Small Lymphocytic Leukemia, ZeuS-2 Trial
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Phase 2Not yet recruitingCity of Hope Medical Center442027-08-042026-09-10
Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse
Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomography - Recurrent Ganglioneuroblastoma, Recurrent Neuroblastoma
Phase 1 / Phase 2RecruitingNational Cancer Institute (NCI)762027-06-252026-10-22
Zipalertinib With Carboplatin and Pemetrexed for the Treatment of Resectable, Stage II-IIIB, Non-Small Cell Lung Cancer
Biospecimen Collection, Carboplatin, Computed Tomography - Lung Non-Squamous Non-Small Cell Carcinoma
Phase 2Not yet recruitingJonsson Comprehensive Cancer Center162027-06-012026-02-05
A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information
Biospecimen Collection, Chest Radiography, Computed Tomography - Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8
Phase 2RecruitingChildren's Oncology Group512027-05-152026-09-24
CCR5 Targeting Leronlimab in Combination With Hepatic Arterial Infusion Floxuridine and Systemic Therapy for the Treatment of Colorectal Cancer Liver Metastases, CHAMP Trial
Biopsy Procedure, Biospecimen Collection, Computed Tomography - Metastatic Colorectal Carcinoma, Metastatic Malignant Neoplasm in the Liver
Phase 1Not yet recruitingCity of Hope Medical Center362027-05-062026-09-25
Enfortumab Vedotin for the Treatment of Unresectable or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer, Anaplastic Thyroid Cancer, Medullary Thyroid Cancer, or NUT Carcinoma
Biopsy Procedure, Biospecimen Collection, Computed Tomography - Metastatic Differentiated Thyroid Gland Carcinoma, Metastatic NUT Carcinoma
Phase 2Not yet recruitingNorthwestern University562027-05-052026-10-07
Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial
Autologous Hematopoietic Stem Cell Transplantation, Biospecimen Collection, Bone Marrow Aspiration - Plasma Cell Leukemia
Phase 2RecruitingNational Cancer Institute (NCI)742027-04-202026-10-26
Genetically Engineered Cells (BAFFR-CAR T Cells) for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia and B-cell Lymphoblastic Lymphoma
Autologous BAFFR-targeting CAR T Cells, Biospecimen Collection, Bone Marrow Aspiration - Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma
Phase 1Not yet recruitingCity of Hope Medical Center162027-04-172026-08-11
Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis
Biopsy Procedure, Biospecimen Collection, Breast Conservation Treatment - Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Positive Breast Carcinoma
Phase 3RecruitingSWOG Cancer Research Network5622027-03-092026-10-13
FPS-ZM1 With or Without Dexamethasone for Controlling Post Operative Cerebral Edema in Patients With Glioblastoma
Biospecimen Collection, Computed Tomography, Dexamethasone - Glioblastoma, Malignant Glioma
Phase 1Not yet recruitingCity of Hope Medical Center242027-02-172026-08-27
Autologous Tumor Infiltrating Lymphocytes With Interleukin-2 for the Treatment of Locally Advanced, Recurrent or Metastatic Gastrointestinal Stromal Tumors
Aldesleukin, Biospecimen Collection, Chest Radiography - Locally Advanced Gastrointestinal Stromal Tumor, Metastatic Gastrointestinal Stromal Tumor
Phase 2Not yet recruitingJoal Beane592027-02-152026-10-13
Testing the Investigational Medication Pembrolizumab After Kidney Removal for Patients With Non-Clear Cell Renal Cell Carcinoma
Biospecimen Collection, Bone Scan, Computed Tomography - Non-Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8
Phase 3Not yet recruitingNational Cancer Institute (NCI)4002027-02-102026-07-08
Testing the Addition of Ivonescimab Combined With Standard Chemotherapy Compared to the Usual Chemotherapy and Immunotherapy Treatment for Patients With Advanced Biliary Tract Cancer
Biospecimen Collection, Cisplatin, Computed Tomography - Locally Advanced Biliary Tract Adenocarcinoma, Locally Advanced Extrahepatic Cholangiocarcinoma
Phase 2 / Phase 3Not yet recruitingECOG-ACRIN Cancer Research Group3362027-01-112026-08-14
Testing the Use of High Dose Testosterone Followed by Darolutamide Compared to the Usual Care for Patients With Metastatic Prostate Cancer
Abiraterone Acetate, Biospecimen Collection, Bone Scan - Metastatic Castration-Resistant Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8
Phase 2 / Phase 3Not yet recruitingECOG-ACRIN Cancer Research Group4322027-01-062026-10-01
Magnetic Resonance-Guided Stereotactic Body Radiation Therapy for the Treatment of Prostate Cancer
Biopsy Procedure, Computed Tomography, Electronic Health Record Review - Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8
Not applicableNot yet recruitingCity of Hope Medical Center202027-01-012026-08-17
Biology Guided Therapy Recommendations for Treatment Determination of Hormone Receptor-Positive Advanced, Unresectable or Metastatic Breast Cancer, ENDORSE Trial
Biopsy Procedure, Biospecimen Collection, Bone Scan - Advanced Hormone Receptor-Positive Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8
Phase 1Not yet recruitingCity of Hope Medical Center202026-12-192026-05-15
Testing Repeat Radiation Therapy for Recurrent Non-small Cell Lung Cancer
Biospecimen Collection, Computed Tomography, Immunotherapy - Locally Recurrent Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8
Phase 2Not yet recruitingNRG Oncology1382026-12-182026-09-23
Elacestrant With Everolimus for the Treatment of Recurrent Advanced or Metastatic ER-Positive Endometrial Cancer
Biospecimen Collection, Computed Tomography, Elacestrant - Advanced Endometrial Carcinoma, Metastatic Endometrial Carcinoma
Phase 2Not yet recruitingJonsson Comprehensive Cancer Center502026-12-182026-06-09

Showing 20 of 645. Sign in to see all of them.

Conditions studied

Prostatic Neoplasms (53)  ·  Lung Neoplasms (49)  ·  Neoplasm Metastasis (39)  ·  Carcinoma, Non-Small-Cell Lung (38)  ·  Glioblastoma (36)  ·  Glioma (29)  ·  Pancreatic Neoplasms (28)  ·  Carcinoma, Renal Cell (27)  ·  Brain Neoplasms (24)  ·  Colorectal Neoplasms (24)  ·  Melanoma (24)  ·  Multiple Myeloma (24)  ·  Urinary Bladder Neoplasms (22)  ·  Breast Neoplasms (21)  ·  Lymphoma (21)

Sponsors

National Cancer Institute (NCI) (238)  ·  Mayo Clinic (74)  ·  City of Hope Medical Center (45)  ·  Children's Oncology Group (28)  ·  M.D. Anderson Cancer Center (26)  ·  NRG Oncology (25)  ·  Jonsson Comprehensive Cancer Center (20)  ·  OHSU Knight Cancer Institute (17)  ·  Emory University (14)  ·  Northwestern University (14)  ·  Roswell Park Cancer Institute (14)  ·  SWOG Cancer Research Network (14)  ·  ECOG-ACRIN Cancer Research Group (11)  ·  University of Washington (11)  ·  Fred Hutchinson Cancer Center (8)

Countries

United States (609)  ·  Canada (88)  ·  Puerto Rico (50)  ·  Australia (29)  ·  New Zealand (13)  ·  Guam (7)  ·  Hong Kong (7)  ·  Saudi Arabia (7)  ·  Japan (5)  ·  South Korea (5)  ·  Ireland (4)  ·  Israel (4)  ·  Switzerland (4)  ·  Singapore (3)  ·  Belgium (2)

Top investigators

Andrea B Apolo (4)  ·  Haider S Mahdi (4)  ·  Joyce F Liu (4)  ·  Terence C. Burns, MD, PhD (4)  ·  A P Chen (3)  ·  Behnam Badie (3)  ·  Funda Meric-Bernstam (3)  ·  Ibrahim Aldoss (3)  ·  Jacob J. Orme, MD, PhD (3)  ·  Marwan G Fakih (3)  ·  Matthew S. Block, MD, PhD (3)  ·  Nilofer S Azad (3)  ·  Patricia M LoRusso (3)  ·  Roman O. Kowalchuk, MD (3)  ·  Rosa Nadal Rios, MD, PhD (3)

Results publications

PMID 37505794, PMID 31401903, PMID 33395032, PMID 35031545, PMID 37185961, PMID 37222189, PMID 38421243, PMID 39571596, PMID 19488737, PMID 23810467, PMID 25218906, PMID 26586415, PMID 27811504, PMID 28029927, PMID 28223062, PMID 29211618, PMID 29223478, PMID 29376112, PMID 30332335, PMID 31335643, PMID 31449468, PMID 31491821, PMID 31969335, PMID 32205218, PMID 32463741, PMID 32597469, PMID 32915679, PMID 32920242, PMID 33048619, PMID 33067126, PMID 33084020, PMID 33152282, PMID 33362722, PMID 33370024, PMID 33591402, PMID 33604999, PMID 33641042, PMID 33843815, PMID 33878954, PMID 33882143, PMID 33927108, PMID 34028986, PMID 34087549, PMID 34292305, PMID 34331515, PMID 34340209, PMID 34357781, PMID 34380093, PMID 34380663, PMID 34448679

NIH funding

P30CA033572 (47), U10CA180868 (47), U10CA180820 (46), U10CA180886 (42), U10CA180821 (33), U10CA180888 (33), P30CA060553 (22), UM1CA186689 (15), UM1CA186709 (15), P30CA138292 (14), UM1CA186691 (12), UM1CA186644 (10), UM1CA186690 (10), UM1CA186712 (10), UM1CA186688 (9)